Chamberlin, Jordan H.
Ogbonna, Alexis
Abrol, Sameer
Maisuria, Dhruw
Miller, Emily
McGuire, Aaron
Knight, Heather
O’Doherty, Jim
Baruah, Dhiraj
Schoepf, U. Joseph
Munden, Reginald F.
Kabakus, Ismail M. https://orcid.org/0000-0002-8745-339X
Article History
Received: 9 December 2023
Accepted: 5 January 2024
First Online: 15 January 2024
Declarations
:
: Reginald F. Munden MD DMD holds stock in Optellum Ltd and Therabionics.Uwe Joseph Schoepf MD received institutional research support and/or personal fees from Bayer, Bracco, Elucid Bioimaging, Guerbet, HeartFlow, Keya Medical, and Siemens.Jim O’Doherty PhD was an employee of Siemens Medical Solutions USA, Inc.The remaining of the authors has no conflict of interest to declare.All co-authors have seen and agree with the contents of the manuscript and there is no financial interest to report.